# Bolt Biotherapeutics, Inc.: Form 8-K, filed Nov 9, 2023

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: 8-K
- Filed: 2023-11-09
- Accepted by EDGAR: Nov 9, 2023, 16:08 ET
- Period: 2023-11-09
- Accession: 0000950170-23-062027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000095017023062027/bolt-20231109.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000095017023062027/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000095017023062027/bolt-20231109.htm

Filed Nov 9, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-062027. Last ingested by Listed: Oct 27, 2026, 17:22 ET. No prices; not investment advice.